Cat antigen desensitization reduces allergic rhinoconjunctivitis symptoms

NEW YORK (Reuters Health) - Desensitization with a Fel d 1-derived peptide antigen (Cat-PAD) reduces allergic rhinoconjunctivitis symptoms up to a year after the start of dosing.

Full Story →